Taken together, these data suggest that genetic variation within the core 9p21 CAD region relates to differential expression not only of ANRIL, but in specific cells or conditions, also of the CDKN2A/B tumor suppressors encoded in the locus. This evidence concerns the gene CDKN2B-AS1 and neoplasm.